ArticleJournal of immunotherapy and precision oncology2025

Circulating Tumor DNA as a Prognostic Biomarker for Selecting Participants to Early Phase Clinical Trials.

Sammy Shaya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.